A recent study by the University of Helsinki has uncovered that a mutation in the RFX6 gene significantly impairs insulin secretion, thereby elevating the risk of type 2 and gestational diabetes among carriers. Notably, this gene mutation is more prevalent in Finland than in other parts of the world.
This article was originally published on MedicalXpress.com